# Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril

> **NCT03730116** · — · COMPLETED · sponsor: **Servier Russia** · enrollment: 1909 (actual)

## Conditions studied

- Arterial Hypertension
- CHD - Coronary Heart Disease

## Interventions

- **DRUG:** bisoprolol/perindopril FDC

## Key facts

- **NCT ID:** NCT03730116
- **Lead sponsor:** Servier Russia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-14
- **Primary completion:** 2019-10-24
- **Final completion:** 2019-10-24
- **Target enrollment:** 1909 (ACTUAL)
- **Last updated:** 2021-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730116, "Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03730116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*